2 results about "Transaminase" patented technology

The invention discloses an acetic acid styracin nanometer capsule and a preparation method thereof. The acetic acid styracin nanometer capsule is prepared from gelatin/gum arabic as a wall material, acetic acid styracin as a core material, tween 20 as an emulsifying agent, and glutamine aminopherase as a curing agent by using a composite coacervation method, and in the process of the preparation, the quantity of the gelatin, the gum arabic, the acetic acid styracin, the tween 20 and the glutamine aminopherase are computed in a mass ratio of 1:1:1-2:1-2:0.25. The acetic acid styracin nanometer capsule has favorable storage stability and heat stability, and can durably and effectively control the release of the core material, wherein the average particle diameter is 168.48nm-211.67nm, and the particle size distribution coefficient is 0.132-0.154. The acetic acid styracin nanometer capsule can be used in the fields of spice, essence, foods, cosmetics, detergents, and the like.

The invention discloses a traditional Chinese medicinal composition for treating hepatitis and a preparation method thereof. The traditional Chinese medicinal composition for treating the hepatitis is prepared from the following raw materials: pseudo-ginseng root, golden thread, baical skullcap root, amur corktree bark, rhubarb, spreading hedyotis herb, snake gall, borneol, calculus bovis factitius, aritificial musk, curcuma aromatica and red yeast. The traditional Chinese medicinal composition for treating the hepatitis can be prepared into multiple common formulations for oral administration. The traditional Chinese medicinal preparation treats the hepatitis by clearing heat, detoxicating, removing blood stasis, eliminating stagnation, invigorating blood circulation, dissolving stasis, detoxicating and normalizing gallbladder, has the obvious effects of improving liver function and inhibiting liver injury and hepatitis virus, addresses both symptoms and root causes, requires a short treatment period, realizes a low relapse rate, and has the obvious pharmacological action of protecting the liver and reducing transaminase and serum bilirubin.